http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4956462-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31f26bd884587818b9d2579ce0c1f509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5323fd442d8a622c3ea5a91d47113e52 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A63B69-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 |
| filingDate | 1989-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1990-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55908906948a46e86f4bba609fdcd487 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c0d8bacfabb3d761457b54cb5f0d72a |
| publicationDate | 1990-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4956462-A |
| titleOfInvention | "Triazolo-pyrimidine intermediates" |
| abstract | There are disclosed a β-lactam compound represented by the formula (I): ##STR1## wherein R 1 represents an acyl group; M represents a hydrogen atom, a protective group of an eliminatable group which is easily hydrolyzable in a human body; B represents a group represented by the formula (b): ##STR2## where at least one of R 2 , R 3 and R 9 represent a group represented by the formula: -A-OR 4 where R 4 represents a hydrogen or a lower alkyl group; and A represents a straight or branched alkylene group having 1 to 6 carbon atoms; and a remaining group or groups are each independently a hydrogen atom; a cyano group; a lower alkyl group which may be substituted by a halogen atom; a carbamoyl group which may be substituted by a lower alkyl group; a cycloalkyl group; or a carboxyl group which may be substituted by a protective group of an eliminatable group which is easily hydrolyzable in a human body, and also when R 9 is -A-OR 4 , R 2 and R 3 may be combined with each other to form an alkylene group having 3 to 4 carbon atoms; and Z represents a nitrogen atom or a group represented by the formula: C-R 10 where R 10 represents a hydrogen atom, a carboxyl group or a lower alkyl group which may be substituted by a hydroxy group or a lower alkoxy group, n or its pharmaceutically acceptable salt, and a process for preparing the same, an intermediate for synthesis of the same and a medicinal composition for bacterially infectious disease therapy containing the same. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009137547-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7795245-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007155738-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8835441-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5347163-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009312312-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006293345-A1 |
| priorityDate | 1987-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1323.